RhumbLine Advisers’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-809
| Closed | -$120K | – | 3131 |
|
|
2021
Q1 | $120K | Sell |
809
-21
| -3% | -$3.12K | ﹤0.01% | 2915 |
|
|
2020
Q4 | $116K | Buy |
830
+62
| +8% | +$8.67K | ﹤0.01% | 2950 |
|
|
2020
Q3 | $117K | Sell |
768
-22
| -3% | -$3.35K | ﹤0.01% | 2842 |
|
|
2020
Q2 | $139K | Buy |
+790
| New | +$139K | ﹤0.01% | 2881 |
|
|
2015
Q2 | – | Sell |
-53
| Closed | -$54K | – | 3104 |
|
|
2015
Q1 | $54K | Buy |
53
+10
| +23% | +$10.2K | ﹤0.01% | 2995 |
|
|
2014
Q4 | $142K | Buy |
43
+2
| +5% | +$6.61K | ﹤0.01% | 2897 |
|
|
2014
Q3 | $120K | Buy |
41
+4
| +11% | +$11.7K | ﹤0.01% | 2905 |
|
|
2014
Q2 | $140K | Buy |
+37
| New | +$140K | ﹤0.01% | 2937 |
|